🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Deutsche Bank raises UnitedHealth stock target on earnings beat

EditorAhmed Abdulazez Abdulkadir
Published 19/04/2024, 10:56
UNH
-

On Friday, Deutsche Bank adjusted its outlook on UnitedHealth Group (NYSE:UNH), increasing the price target to $562 from $545, while maintaining a Buy rating on the stock. The adjustment followed UnitedHealth's first-quarter earnings report, which surpassed expectations despite several challenges, including a cyber attack on Change Healthcare (NASDAQ:CHNG).

UnitedHealth reported a quarterly earnings beat, although the quality of earnings and guidance were left open to investors' interpretation due to the cyber incident's impact. The analysis suggested that the full effect of the hack, along with conservative estimates around cost trends and utilization, would likely reduce UnitedHealth's earnings by approximately 2% for the entire year.

Investors had been keenly awaiting UnitedHealth's medical loss ratio (MLR) as a marker of cost trends and an indicator for other managed care organizations' (MCOs) performance. UnitedHealth posted a composite MLR of 84.3%, roughly 100 basis points above the guidance provided before the quarter.

This figure included a significant reserve increase due to anticipated, but not yet incurred, Change Healthcare claims, as well as costs stemming from relaxed prior authorizations in response to the cyber attack.

Despite these challenges, UnitedHealth has decided to maintain its core guidance for the year, which ranges from $27.50 to $28.00 in earnings per share (EPS). The company is accounting for additional expenses related to the Change Healthcare cyber attack, estimating an EPS impact between 85 cents and $1.00, while absorbing costs of 30 to 40 cents per share due to the incident.

In conclusion, while the first-quarter MLR was slightly higher than anticipated, the overall outlook for the year aligns with previous expectations, offering reassurance to investors about medical cost trends and their potential impact on earnings.

InvestingPro Insights

Following the recent earnings report and Deutsche Bank's updated price target for UnitedHealth Group (NYSE:UNH), investors may benefit from additional insights. UnitedHealth's management has demonstrated confidence in the company's financial health through aggressive share buybacks and a consistent track record of dividend increases, having raised its dividend for 14 consecutive years. This commitment is further underscored by the company maintaining dividend payments for 32 consecutive years, reinforcing its stability and reliability as an investment.

InvestingPro real-time data indicates that UnitedHealth Group has a robust market capitalization of $454.68 billion, with a P/E ratio of 20.61, reflecting the company's strong earnings. The revenue growth over the last twelve months as of Q1 2024 stands at 12.96%, showcasing solid top-line expansion. Additionally, the company has seen a significant return over the last week, with a 1-week price total return of 12.29%, which is particularly notable given the broader market conditions.

For those looking to delve deeper into UnitedHealth's performance and prospects, InvestingPro offers additional InvestingPro Tips. Currently, there are 13 more tips available that can provide valuable insights into the company's financial health, industry position, and future profitability. To access these tips and enhance your investment strategy, utilize the coupon code PRONEWS24 for an additional 10% off a yearly or biyearly Pro and Pro+ subscription at Investing.com/pro/UNH.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.